(1)
In Silico Study of New Five-Membered Heterocyclic Derivatives Bearing (1,3,4-Oxadiazole and 1,3,4-Thiadiazole) As Promising Cyclooxygenase Inhibitors. AJPS 2024, 24 (3), 237-251. https://doi.org/10.32947/ajps.v24i3.1060.